We proposed that XHP can function as an effective TBNC inhibitor by preventing cancer cell proliferation and angiogenesis, as well as enhancing cancer cell apoptosis mainly through inhibiting EGFR-PI3K-AKT signaling pathway (Figure 6). The gene discussed is AKT1; the disease is cancer.